Duearity AB (DEAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Duearity AB (DEAR) has a cash flow conversion efficiency ratio of 0.036x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-416.00K ≈ $-44.77K USD) by net assets (Skr-11.54 Million ≈ $-1.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Duearity AB - Cash Flow Conversion Efficiency Trend (2020–2023)
This chart illustrates how Duearity AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read DEAR total debt and obligations for a breakdown of total debt and financial obligations.
Duearity AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Duearity AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cardiff Property PLC
LSE:CDFF
|
-0.046x |
|
LeddarTech Holdings Inc
NASDAQ:LDTC
|
0.084x |
|
Glob Bioenergi
PA:ALGBE
|
-3.463x |
|
PBT Group Ltd
JSE:PBG
|
0.295x |
|
Subsea 7 SA
LSE:0OGK
|
-0.030x |
|
Carclo plc
LSE:CAR
|
-0.047x |
|
Challenger Energy Group PLC
LSE:CEG
|
-0.008x |
|
Rajvir Industries Limited
NSE:RAJVIR
|
-0.158x |
Annual Cash Flow Conversion Efficiency for Duearity AB (2020–2023)
The table below shows the annual cash flow conversion efficiency of Duearity AB from 2020 to 2023. For the full company profile with market capitalisation and key ratios, see Duearity AB market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | Skr-2.39 Million ≈ $-256.77K |
Skr-24.36 Million ≈ $-2.62 Million |
10.207x | +404.16% |
| 2022-12-31 | Skr6.06 Million ≈ $652.48K |
Skr-20.35 Million ≈ $-2.19 Million |
-3.356x | -174.66% |
| 2021-12-31 | Skr11.04 Million ≈ $1.19 Million |
Skr-13.49 Million ≈ $-1.45 Million |
-1.222x | -331.51% |
| 2020-12-31 | Skr3.79 Million ≈ $408.19K |
Skr-1.07 Million ≈ $-115.58K |
-0.283x | -- |
About Duearity AB
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help pe… Read more